Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger J. Packer

Showing results (91-100 of 279) with videos related to

Pageof 28
Sort By:
Neuro-Oncology|January 13, 2018
Response to Harreld re: "Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology Committee"Katherine E Warren, Gilbert Vezina, Tina Y Poussaint, et al.
Neurology|November 6, 2016
Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1Robert A Avery, Awais Mansoor, Rabia Idrees, et al.
Pediatric Blood & Cancer|January 24, 2009
Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecanRoger J Packer, Regina Jakacki, Marianna Horn, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|February 27, 2014
Treatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a reviewThora Gudrunardottir, Birgitta Lannering, Marc Remke, et al.
Neurology|May 13, 2016
Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1Robert A Avery, Awais Mansoor, Rabia Idrees, et al.
Pediatric Neurology|September 13, 2011
Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I studyMaria T Acosta, Peter G Kardel, Karin S Walsh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Phase I study of O6-benzylguanine and temozolomide administered daily for 5 days to pediatric patients with solid tumorsKatherine E Warren, Alberta A Aikin, Madeleine Libucha, et al.
Ophthalmology|November 8, 2016
Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for CareRobert A Avery, James A Katowitz, Michael J Fisher, et al.
The Oncologist|April 17, 2003
Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumorsTobey J MacDonald, Brian R Rood, Maria R Santi, et al.
Pediatric Neurology|December 15, 2010
Center for Neuroscience and Behavioral Medicine: an innovative administrative structure and possible paradigm for the futureRoger J Packer, Jocelyn Villongco, Mark Batshaw, et al.
Pageof 28

Showing results (91-100 of 279) with videos related to

Sort By:
Pageof 28
Neuro-Oncology|January 13, 2018
Response to Harreld re: "Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology Committee"Katherine E Warren, Gilbert Vezina, Tina Y Poussaint, et al.
Neurology|November 6, 2016
Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1Robert A Avery, Awais Mansoor, Rabia Idrees, et al.
Pediatric Blood & Cancer|January 24, 2009
Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecanRoger J Packer, Regina Jakacki, Marianna Horn, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|February 27, 2014
Treatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a reviewThora Gudrunardottir, Birgitta Lannering, Marc Remke, et al.
Neurology|May 13, 2016
Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1Robert A Avery, Awais Mansoor, Rabia Idrees, et al.
Pediatric Neurology|September 13, 2011
Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I studyMaria T Acosta, Peter G Kardel, Karin S Walsh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Phase I study of O6-benzylguanine and temozolomide administered daily for 5 days to pediatric patients with solid tumorsKatherine E Warren, Alberta A Aikin, Madeleine Libucha, et al.
Ophthalmology|November 8, 2016
Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for CareRobert A Avery, James A Katowitz, Michael J Fisher, et al.
The Oncologist|April 17, 2003
Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumorsTobey J MacDonald, Brian R Rood, Maria R Santi, et al.
Pediatric Neurology|December 15, 2010
Center for Neuroscience and Behavioral Medicine: an innovative administrative structure and possible paradigm for the futureRoger J Packer, Jocelyn Villongco, Mark Batshaw, et al.
Pageof 28